≡
🔎︎
🔎︎
Roundtables
Podcasts
Viewpoints
Conferences
HEALTHCARE HEADLINES
FDA & Regulations
Policy & Legislation
Healthcare Systems & Business
Digital Health & AI
Workforce & Practice
Clinical Trial Updates
ONCOLOGY CARE
GU Cancers
Hematologic Malignancies
Breast Cancer
Lung & Thoracic
GI Cancers
Dermatologic Cancer
Supportive & Survivorship Care
PRECISION MEDICINE
Biomarker & Genomic Testing
Transplant Diagnostics
Liquid Biopsy & MRD
Companion Diagnostics
Cell & Gene Therapy
SPECIALTY MEDICINE
Cardiology
Dermatology & Allergy
Endocrinology & Metabolic
Pulmonology
GI & Hepatology
ID & Vaccines
NEUROLOGY & MENTAL HEALTH
Alzheimer's & Dementia
Multiple Sclerosis
Migraine & Headache
Psychiatry & Behavioral Health
Movement Disorders
Rare Neurological Diseases
ACCESS & AFFORDABILITY
Prior Authorization
Patient Assistance & Hubs
Biosimilars & Generics
Drug Pricing & Out-of-Pocket
Coverage & Appeals
MANAGED CARE
Formulary & Coverage
Value Based Care
Pharmacy Benefit Trends
Population Health Management
Payer Policy & Regulation
Pulmonology
Air Quality Alerts Blanket the Northeast as Canadian Smoke Pushes the AQI Into the Unhealthy Band
George Padron
Specialty Medicine
,
Healthcare Headlines
,
Workforce & Practice
,
Pulmonology
| Jul 16, 2026
Wildfire smoke drove Northeast air quality into the Unhealthy band Thursday. At AQI 151 to 200, the guidance covers everyone, and only KN95 or N95 masks help.
Public Healthcare Costs Associated With Smoking in Hong Kong
George Padron
Specialty Medicine
,
Pulmonology
,
Managed Care
,
Population Health Management
| Jul 9, 2026
A Hong Kong cohort of 1.57 million ties smoking to higher outpatient, emergency, and hospital costs, with women's cost multipliers exceeding men's.
Datopotamab Deruxtecan Anchors Post-TKI Care in EGFR-Mutant Lung Cancer, MSK Oncologist Says
George Padron
Oncology Care
,
Biomarker & Genomic Testing
,
Specialty Medicine
,
Lung & Thoracic
,
Pulmonology
| May 20, 2026
MSK's Helena Yu describes how datopotamab deruxtecan now anchors post-TKI care for EGFR-mutant lung cancer when no targetable resistance mechanism is found on re-biopsy
Undiagnosed and Undertreated Sleep Apnea Costs U.S. Employers More Than $180 Billion Annually
George Padron
Specialty Medicine
,
Pulmonology
| Mar 14, 2026
A study estimates OSA syndrome costs U.S. employers over $180 billion yearly in productivity losses, making the case for broader screening and CPAP coverage.
Load More
Latest News
Mapping Parkinson's Genetics Beyond European Ancestry
Aug 5, 2026
Putting a Price on Exercise After Colon Cancer Treatment
Aug 4, 2026
AI for Managed Care Administration: Enhancement or Replacement? (Part 2)
Aug 3, 2026
A Bispecific Moved Earlier in Myeloma, and Brought Its Infection Risk With It
Aug 2, 2026
A Blood Test's Blind Spots: Discrepancies Between P-tau217 and Clinical Alzheimer's Disease
Aug 1, 2026
Only Healthcare Today
Covering Clinical Healthcare, Access and Cost
1 Hewitt Square, Suite 139
East Northport, NY 11731
Who We Are
About Us
Editorial Policy
Contributors & Partners
Connect
Contact Us
Work With Us
Advertising
Terms of Use
Privacy Policy
x
Search